Z

Zynerba Pharmaceuticals Inc
F:6ZY

Watchlist Manager
Zynerba Pharmaceuticals Inc
F:6ZY
Watchlist
Price: 1.26 EUR 2.44% Market Closed
Market Cap: 67.6m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of 6ZY.

The Intrinsic Value is calculated as the average of DCF and Relative values:

6ZY Intrinsic Value
Not Available
Z
Base Case Scenario
Compare 6ZY to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 6ZY?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Zynerba Pharmaceuticals Inc

Current Assets 39.3m
Cash & Short-Term Investments 36m
Receivables 1.3m
Other Current Assets 2m
Non-Current Assets 1.2m
PP&E 613.9k
Other Non-Current Assets 567.7k
Current Liabilities 11.5m
Accounts Payable 2.5m
Accrued Liabilities 9m
Other Current Liabilities -10
Efficiency

Free Cash Flow Analysis
Zynerba Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Zynerba Pharmaceuticals Inc

Revenue
0 USD
Operating Expenses
-38.8m USD
Operating Income
-38.8m USD
Other Expenses
1.2m USD
Net Income
-37.6m USD
Fundamental Scores

6ZY Profitability Score
Profitability Due Diligence

Zynerba Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

Low 3Y Average Gross Margin
Low 3Y Average Net Margin
Low 3Y Average Operating Margin
Declining ROE
21/100
Profitability
Score

Zynerba Pharmaceuticals Inc's profitability score is 21/100. The higher the profitability score, the more profitable the company is.

6ZY Solvency Score
Solvency Due Diligence

Zynerba Pharmaceuticals Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Low Altman Z-Score
58/100
Solvency
Score

Zynerba Pharmaceuticals Inc's solvency score is 58/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

6ZY Price Targets Summary
Zynerba Pharmaceuticals Inc

There are no price targets for 6ZY.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 6ZY is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y